Xylem (NYSE:XYL) Price Target Raised to $162.00 at Royal Bank of Canada

Xylem (NYSE:XYL) had its target price boosted by Royal Bank of Canada from $157.00 to $162.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the industrial products company’s stock.

XYL has been the subject of several other reports. Robert W. Baird lifted their price target on Xylem from $151.00 to $155.00 and gave the company an outperform rating in a research report on Friday. Oppenheimer raised their price objective on shares of Xylem from $142.00 to $147.00 and gave the company an outperform rating in a research report on Friday. Stifel Nicolaus upped their target price on shares of Xylem from $136.00 to $150.00 and gave the stock a buy rating in a report on Wednesday, February 7th. Raymond James raised shares of Xylem from an underperform rating to a market perform rating in a report on Thursday, January 4th. Finally, BNP Paribas started coverage on shares of Xylem in a report on Tuesday, March 12th. They issued an outperform rating and a $150.00 price target on the stock. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average price target of $140.70.

Xylem Price Performance

Shares of NYSE XYL opened at $139.21 on Friday. The firm has a market cap of $33.75 billion, a price-to-earnings ratio of 49.54, a price-to-earnings-growth ratio of 2.67 and a beta of 1.08. The stock has a fifty day simple moving average of $128.91 and a two-hundred day simple moving average of $115.87. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19. Xylem has a 1-year low of $87.59 and a 1-year high of $139.21.

Xylem (NYSE:XYL) last released its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. During the same period in the prior year, the firm earned $0.72 earnings per share. The company’s revenue was up 40.4% compared to the same quarter last year. Analysts anticipate that Xylem will post 4.24 earnings per share for the current year.

Insider Transactions at Xylem

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Xylem by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock worth $3,207,683,000 after acquiring an additional 187,847 shares during the last quarter. Morgan Stanley increased its holdings in Xylem by 11.5% during the 3rd quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock valued at $412,267,000 after purchasing an additional 466,911 shares during the period. Invesco Ltd. raised its position in Xylem by 35.1% during the 3rd quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock valued at $380,762,000 after purchasing an additional 1,086,102 shares during the last quarter. Royal Bank of Canada lifted its holdings in Xylem by 10.6% in the 3rd quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock worth $310,249,000 after buying an additional 327,383 shares during the period. Finally, Baillie Gifford & Co. grew its position in shares of Xylem by 2.3% in the 4th quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock worth $350,701,000 after buying an additional 69,619 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.